NEW CCR5 MODULATORS: BENZIMIDAZOLES OR BENZOTRIAZOLES
申请人:AstraZeneca AB
公开号:EP1265870A1
公开(公告)日:2002-12-18
US6989393B2
申请人:——
公开号:US6989393B2
公开(公告)日:2006-01-24
[EN] NEW CCR5 MODULATORS: BENZIMIDAZOLES OR BENZOTRIAZOLES<br/>[FR] BENZIMIDAZOLES OU BENZOTRIAZOLES EN TANT QUE NOUVEAUX MODULATEURS DE CCR5
申请人:ASTRAZENECA AB
公开号:WO2001066525A1
公开(公告)日:2001-09-13
The invention concerns compounds of formula (I), wherein the variables are defined herein; processes for preparing them, compositions comprising them and their use in modulating CCR5 receptor activity.
Ccr5 modulators benzimidazoles or benzotriazoles
申请人:——
公开号:US20030119869A1
公开(公告)日:2003-06-26
The invention concerns compounds of formula (I), wherein the variables are defined herein; processes for preparing them, compositions comprising them and their use in modulating CCR5 receptor activity.